Decoding neuronal vulnerability: Multidimensional analysis of D1R ‐ and D2R ‐ medium‐sized spiny neurons in Huntington's disease
Brain Pathology · 2026
DOI: 10.1111/bpa.70135 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Pathology, 2026. Verfasst von Guendalina Bergonzoni und 22 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of NeuroEpigenetics, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy. Hauptthemen laut MEDLINE: Huntington Disease, Receptors, Dopamine D1, Medium Spiny Neurons, Receptors, Dopamine D2. Die Arbeit nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, European Regional Development Fund, NINDS NIH HHS.
Abstract (Originalsprache)
Understanding the molecular mechanisms driving selective neuronal vulnerability to different neurodegenerative disorders remains a crucial, unsolved question. Here, we explored the case of Huntington's disease (HD), where the striatum and, specifically, dopamine receptor 1 (D1R) and dopamine receptor 2 (D2R) medium‐sized spiny neurons (MSNs) exhibit differential susceptibility to the HTT CAG‐repeat expansion mutation, with D2R‐neurons being impacted earlier and more significantly. To unravel differences between D2R and D1R MSNs, we employed a multidimensional approach, integrating genomic, transcriptional, pattern distribution, and somatic instability analyses. Specifically, we used Htt CAG knock‐in mouse models harboring 18 ( Htt Q20 : “control”) or ~190 ( Htt Q175 : “HD”) consecutive CAG repeats, expressing tdTomato and EGFP under the control of Drd1 and Drd2 promoters, respectively. First, comprehensive genomic and transcriptomic analyses following fluorescence‐activated cell sorting (FACS) of dissociated striatal neurons revealed distinct gene expression profiles with a significant upregulation of oxidative phosphorylation and translation pathways in D1R‐positive neurons already at the pre‐symptomatic stage. These transcriptional changes were not accompanied by major copy number variations, as shown by parallel genomic analysis. Secondly, histological analyses revealed a greater proportion of D1R‐positive neurons compared to D2R‐positive neurons in HD mice, particularly in the ventral‐medial neostriatum, with D2R‐positive neurons presenting an increased nuclear accumulation of mutant huntingtin aggregates. In summary, our integrative study suggests that the distinct vulnerability of MSNs in HD might result from a combination of an early transcriptional compensatory response of D1R neurons together with specific susceptibility of D2R neurons.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of NeuroEpigenetics, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
- Molecular Biotechnology Center, Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
- Department of Human Genetics, KU Leuven, Leuven, Belgium.
- Computational Genomics Laboratory, International School for Advanced Studies (SISSA), Trieste, Italy.
- Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Guendalina Bergonzoni, Lorenzo Graziani, Denise Ferrarini, Solaleh Khoramian Tusi, Esaria Oliver, Jarne Geurts, Sara Vinciguerra, Michele Tebaldi, Takshashila Tripathi, Isabella Pesce, Alessandro Romanel, Rosario Moratalla, Jasmin Morandell, Remo Sanges, Erik Dassi, Marta Biagioli
Förderung
- NIH HHS
- European Regional Development Fund
- NINDS NIH HHS
- Italian Ministry of University and Research (MUR)
- Marie Skłodowska Curie reintegration fellowship (the European Union's Horizon 2020 Research and Innovation Program)
- Ministero dell'Università e della Ricerca
- National Institutes of Health
Zitieren
APA
Bergonzoni, G., Pellegrini, M., Savino, A., Lazioli, M., Geurs, S., Graziani, L., Ferrarini, D., Tusi, S. K., Oliver, E., Geurts, J., Vinciguerra, S., Tebaldi, M., Tripathi, T., Pesce, I., Poli, V., Romanel, A., Moratalla, R., Voet, T., Morandell, J., …, & Biagioli, M. (2026). Decoding neuronal vulnerability: Multidimensional analysis of D1R ‐ and D2R ‐ medium‐sized spiny neurons in Huntington's disease. Brain Pathology. https://doi.org/10.1111/bpa.70135
Vancouver
Bergonzoni G, Pellegrini M, Savino A, Lazioli M, Geurs S, Graziani L, et al. Decoding neuronal vulnerability: Multidimensional analysis of D1R ‐ and D2R ‐ medium‐sized spiny neurons in Huntington's disease. Brain Pathology. 2026. doi:10.1111/bpa.70135
BibTeX
@article{Bergonzoni2026,
author = {Bergonzoni, Guendalina and Pellegrini, Miguel and Savino, Aurora and Lazioli, Martina and Geurs, Sarah and Graziani, Lorenzo and Ferrarini, Denise and Tusi, Solaleh Khoramian and Oliver, Esaria and Geurts, Jarne and Vinciguerra, Sara and Tebaldi, Michele and Tripathi, Takshashila and Pesce, Isabella and Poli, Valeria and Romanel, Alessandro and Moratalla, Rosario and Voet, Thierry and Morandell, Jasmin and Sanges, Remo and Wheeler, Vanessa C and Dassi, Erik and Biagioli, Marta},
title = {Decoding neuronal vulnerability: Multidimensional analysis of D1R ‐ and D2R ‐ medium‐sized spiny neurons in Huntington's disease},
journal = {Brain Pathology},
year = {2026},
doi = {10.1111/bpa.70135}
}
EUVIMED